FDA OKs First Oral NMDA Receptor Antagonist for Depression

(MedPage Today) -- The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.
Dextromethorphan-bupropion is an oral...